Page last updated: 2024-10-29

iohexol and Primary Hyperparathyroidism

iohexol has been researched along with Primary Hyperparathyroidism in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Twenty patients had solitary parathyroid adenomas, two patients had two adenomas resected, two patients did not have an adenoma, and one patient had mild four-gland hyperplasia."1.37Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. ( Beland, MD; Grand, DJ; Machan, JT; Mayo-Smith, WW; Monchik, JM, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beland, MD1
Mayo-Smith, WW1
Grand, DJ1
Machan, JT1
Monchik, JM1

Other Studies

1 other study available for iohexol and Primary Hyperparathyroidism

ArticleYear
Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism.
    AJR. American journal of roentgenology, 2011, Volume: 196, Issue:1

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Four-Dimensional Computed Tomograph

2011